CYBN Stock Analysis: Buy, Sell, or Hold?
CYBN - Cybin Inc.
$8.28
0.10 (1.22%)
â˛
5d:
+0.85%
30d:
+50.27%
90d:
+33.33%
WAIT
LOW Confidence
Analysis Updated: Jan 2, 2026 12:00 AM ET
Earnings: Feb 09, 2026
0d
Get Alerted When CYBN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: CYBN is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: CYBN is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: CYBN is currently trading at $8.28, which is considered fair based on recent price action.
Technical Outlook: Technically, CYBN is showing sideways momentum. Immediate support is located at $6.75, while resistance sits at $9.12.
Market Sentiment: CYBN scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $48.00 (+479.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CYBN is showing sideways momentum. Immediate support is located at $6.75, while resistance sits at $9.12.
Market Sentiment: CYBN scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $48.00 (+479.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
39/100
(SELL)
Volume Confirmation
UNKNOWN
Confidence Score
81.6%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (75/100)
- BULLISH: Trading 479.7% below Wall St target ($48.00)
- WARNING: Composite score 39/100 in the bottom quintile â this cohort historically lags the market
Support & Resistance Levels
Support Level
$6.75
Resistance Level
$9.12
Current Trend
Sideways
Technical data as of
Jan 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.05
Wall Street Target
$48.00
(+479.7%)
Share & Embed Analysis
Last updated: August 23, 2026 10:10 PM ET
Data refreshes hourly during market hours. Next update: 11:10 PM
Data refreshes hourly during market hours. Next update: 11:10 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CYBN showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical âĻ |
STRONG BUY
29 analysts |
$91 | 42 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 66 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$35 | 50 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$108 | 52 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$127 | 41 HOLD |
